8-溴-4-羟基喹啉-2-羧酸甲酯 | 495407-02-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 8-溴-4-羟基喹啉-2-羧酸甲酯
• 英文名称: methyl 4-hydroxy-8-bromo-quinoline-2-carboxylate
• 英文别名: methyl 8-bromo-4-hydroxyquinoline-2-carboxylate；methyl 8-bromo-4-oxo-1H-quinoline-2-carboxylate
• CAS: 495407-02-8；942227-30-7
• 化学式: C₁₁H₈BrNO₃
• 分子量: 282.093
• InChiKey: MSNCAHIJLBCEDO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  8-amino-1,4-dihydro-4-oxo-2-quinolinecarboxylic acid methyl ester 、 8-溴-4-羟基喹啉-2-羧酸甲酯 生成 8-溴-4-羟基喹啉-2-羧酸
  参考文献：
  名称：

  Compositions derived from quinoline and quinoxaline, preparation and use thereof

  摘要：

  本发明涉及从喹啉和喹喔啉衍生的化合物，它们的制备和用途，特别是在治疗和疫苗领域或用于开发活性化合物方面。本发明的化合物的一般式（I）及其药学上可接受的盐。

  公开号：

  US20060183909A1
• 作为产物：
  描述：

  Dimethyl 2-(2-Bromophenyl)amino-2-butene-1,4-dioate 在 四磷十氧化物 作用下， 以95%的产率得到8-溴-4-羟基喹啉-2-羧酸甲酯
  参考文献：
  名称：

  A Mild and Efficient Synthesis of 4-Quinolones and Quinolone Heterocycles

  摘要：

  The cycloacylation of aniline derivatives to 4-quinolones in the presence of Eaton's reagent is described. This high-yielding methodology is applicable to a wide variety of functionalized anilines and requires milder conditions than those traditionally employed. This cyclization protocol is used to prepare a host of heterocycles and bis-quinolones and is characterized by relatively low reaction temperature and ease of product isolation.

  DOI：

  10.1021/jo070181o

文献信息

• Therapeutic Heterocyclic Compounds 507
  申请人：Pierson Edward

  公开号：US20080076759A1

  公开（公告）日：2008-03-27

  Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5 HT 1B and 5 HT 1D antagonists.

  本文提供的化合物具有以下公式（I）：其中这些化合物可用于治疗精神障碍，包括但不限于抑郁症、广泛性焦虑症、进食障碍、痴呆症、恐慌症和睡眠障碍。这些化合物也可能有助于治疗胃肠障碍、心血管调节、运动障碍、内分泌障碍、血管痉挛和性功能障碍。这些化合物是5HT1B和5HT1D受体拮抗剂。
• Novel spirochromanone derivatives
  申请人：Yamakawa Takeru

  公开号：US20070021453A1

  公开（公告）日：2007-01-25

  The invention relates to a compound of a formula (I): or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.

  该发明涉及一种公式（I）的化合物，或其药学上可接受的盐或酯，用作治疗各种与ACC相关的疾病的治疗剂。
• Spirochromanone derivatives
  申请人：Merck & Co., Inc.

  公开号：US07410976B2

  公开（公告）日：2008-08-12

  The invention relates to a compound of a formula (I): or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.

  本发明涉及一种式(I)的化合物，或其药学上可接受的盐或酯，作为治疗各种与ACC相关的疾病的治疗剂。
• Spirochromanone derivatives as acetyl coenzyme A carboxylase (ACC) inhibitors
  申请人：Merck Sharp & Dohme Corp.

  公开号：US07935712B2

  公开（公告）日：2011-05-03

  The invention relates to a compound of a formula (I): or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.

  本发明涉及一种式（I）的化合物，或其药学上可接受的盐或酯，用作治疗各种与ACC相关的疾病的治疗剂。
• SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS
  申请人：Yamakawa Takeru

  公开号：US20090131464A1

  公开（公告）日：2009-05-21

  The invention relates to a compound of a formula (I): or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.

  本发明涉及一种式(I)的化合物，或其药学上可接受的盐或酯，用作治疗各种与ACC相关的疾病的治疗剂。